Ukuhlolwa kwesifo sikashukela kukhombisa izimpawu zempilo ephansi ezigulini ezi-1 kwezi-5
IzindabaIsifo sikashukela singesinye sezifo ezingapheli ezivamile eMelika, ngokusho kweCenters for Disease Control and Prevention ( i-CDC ), kanye nokwanda kwesifo sikashukela kuyanda. Ku-2018, abantu abayizigidi ezingama-34.2 babenesifo sikashukela. Lokho kungu-10.5% wabantu base-U.S. Izindleko zesifo sikashukela nazo ziyenyuka. Izindleko zokwelashwa ezilinganiselwayo ngomuntu ngamunye onesifo sikashukela zikhuphukile zisuka ku- $ 8,417 ngo-2012 zaya ku- $ 9,601 ngo-2017.
AbakwaSingleCare bahlola abantu abangama-500 abanesifo sikashukela ukuze bafunde kabanzi ngalesi simo, izinketho zokwelashwa kwaso, nemiphumela yaso ezimpilweni nasezikhwameni zaseMelika.
OKUSHIWO: Izibalo zesifo sikashukela
Isifinyezo sokutholakele:
- 1 kwabangu-5 abaphendulile babike ukuthi izimpawu zabo zehlisa izinga labo lempilo.
- Abaphenduli abasebasha kubikwa ukuthi bathintwa kabi yisifo sikashukela kunabaphenduli asebekhulile.
- Cishe izingxenye ezimbili kwezintathu zabaphenduli kubikwa ukuthi zikhathazekile ngokuthi isimo sabo siyingcuphe yokuthola i-COVID-19.
- Uhlobo oluvame kakhulu lwemithi yesifo sikashukela phakathi kwalabo abathatha inhlolovo ngama-biguanides afana ne-metformin.
- I-insulin esebenza isikhathi eside uhlobo oluvame kakhulu lwe-insulini phakathi kwabathathi bethu bohlolo.
- Ukuchama njalo, ukukhathala, nezimpawu ze-GI kubikwa ukuthi yimiphumela emibi kakhulu yemithi yesifo sikashukela noma i-insulin.
- Ama-54% wabaphenduli bakhokhela ephaketheni ukunakekelwa kwesifo sikashukela.
1 kwabangu-5 abaphendulile babike ukuthi izimpawu zabo zehlisa izinga labo lempilo
Njengesifo esingelapheki, akumangazi ukuthi isifo sikashukela sithinta impilo yansuku zonke ezigulini eziningi zikashukela. Ukwelashwa kwesifo sikashukela imvamisa idinga ukushintshwa kwempilo enempilo kanye nemithi yansuku zonke, futhi ama-74% wabathathi bezinhlolovo babike ukuthi banenkinga eyengeziwe yengqondo kanye / noma yempilo yomzimba (comorbidity).
- Kubikwa ukuthi ama-48% adla okunempilo.
- Ama-25% alabo okubikwa ukuthi badla okunempilo baphinde babika ukuthi abanazo izinkinga zesifo sikashukela noma izimo ze-comorbid.
- Kubikwa ukuthi u-30% uzivocavoca kakhulu.
- Ama-24% alabo okuthiwa bazivocavoca kakhulu futhi babike ukuthi abanazo izinkinga zesifo sikashukela noma izimo ze-comorbid.
- Kubikwa ukuthi u-30% unamandla amancane okwenza imisebenzi yansuku zonke.
- U-29% kubikwa ukuthi ukhathazekile ngesimo sabo kanye / noma nezinkinga zesifo sikashukela.
- Ama-34% alaba abaphendulile nawo aba nemiphumela engemihle ye-GI (ukucasula isisu, igesi, isifo sohudo, isicanucanu, ukuhlanza), kanti u-57% naye ubike ukuthi une-hypertension.
- Abangu-19% babike ukuthi izimpawu zabo zehlisa izinga labo lempilo.
- Kulaba abaphendulile, u-13% uphinde wabika ukwehla kwesisindo, u-21% wabika ukutheleleka ngemvubelo, ama-20% abika umfutho wegazi ophansi, kwathi ama-32% abika ukuphelelwa umoya njengemiphumela emibi yemithi yesifo sikashukela.
- Kulaba abaphendulile, u-16% uphinde wabika ukuthi unesifo sezinso kwathi u-15% wabika nokuthi unezifo zesibindi ezinamafutha ezingezona utshwala.
- U-18% kubikwa ukuthi ucindezelekile ngesimo sabo.
- Abangu-17% babike ukuthi isimo sabo asithinti impilo yabo yansuku zonke.
- Abangaphezu kwesigamu (55%) balaba abaphendulile babike nokuthi abayithathi imishanguzo yesifo sikashukela noma i-insulin.
- Uhhafu (51%) walaba bantu abaphendulile baphinde babika ukuthi abangahlangabezani nezinkinga zesifo sikashukela noma izimo ze-comorbid.
- Abangu-16% babike ukuthi isimo sabo sivimba ukuzethemba kwabo.
- Kulaba abaphendulile, u-45% uphinde wabika ukuthi une-hypertension, u-17% uphinde wabika ukuthi une-hyperlipidemia noma i-dyslipidemia, u-18% uphinde wabika ukuthi unesifo sezinso, u-20% wabikwa ukuthi unesifo sesibindi esinamafutha angenalo utshwala, u-16% uphinde wabika ukuthi unesilonda ezinyaweni, u-15% uphinde wabika ukuba nomlando we-ketoacidosis yesifo sikashukela.
- Abangu-15% babike ukuthi imikhuba yabo yokunakekelwa yisifo sikashukela ibavumele ukuba baphile impilo ephelele.
- Cishe ikota (21%) yalabo okubikwa ukuthi baphila impilo enempilo futhi babike ukuthi abanazo izinkinga zesifo sikashukela noma izimo ezi-comorbid.
- U-13% kubikwa ukhathazekile ngokuthi bazoyithenga kanjani imishanguzo kanye nempahla yabo yesifo sikashukela.
- Abangu-8% babike ukuthi isimo sabo sithinte kabi ukusebenza kwesikole noma kokusebenza kwabo.
- Abangu-8% babike ukuthi isimo sabo sibuthinte kabi ubudlelwano babo.
- Laba abaphenduli baphinde babika ukuthi banezinkinga zesifo sikashukela kakhulu noma izimo ezi-comorbid. Kulaba abaphendulile, u-19% uphinde wabika ukuthi unesifo senhliziyo, u-60% uphinde wabika ukuthi unesifo somfutho wegazi ophezulu, u-60% uphinde wabika ukuthi ukhuluphele ngokweqile noma ukhuluphele kakhulu, u-24% uphinde wabika ukuthi unesifo senhliziyo, u-24% ubike nokuthi unesifo sezinso, u-52% ubike nokuthi unaso ukungaboni, futhi u-29% ubike nokuthi unesilonda ezinyaweni.
- Abangu-1% babike ezinye izindlela isimo sabo esinomthelela empilweni yabo yansuku zonke.
OKUSHIWO: Amazinga ajwayelekile kashukela egazini
Abaphenduli abasebasha kubikwa ukuthi bathintwa kabi yisifo sikashukela kunabaphenduli asebekhulile
Abaphenduli abaneminyaka engamashumi amabili nanhlanu kuya kwengu-34 bavame ukubika imithelela emibi ye- ama-prediabetes / isifo sikashukela empilweni yansuku zonke.
- Ama-31% aleli qembu leminyaka abike ukuthi izimpawu zawo zehlise izinga lawo lempilo.
- Ama-28% aleli qembu lobudala abike ukuthi isimo sawo sivimba ukuzethemba kwabo.
- U-28% wale minyaka yobudala kubikwa ukuthi ucindezelekile ngesimo sabo.
- Ama-27% ale minyaka yobudala kubikwa ukuthi akhathazekile ngesimo sawo kanye / noma nezinkinga zawo.
- U-21% wale minyaka yobudala ubike ukuthi isimo sabo sibuthinte kabi ubudlelwano babo.
- U-15% wale minyaka yobudala ubike ukuthi isimo sabo sithinte kabi ukusebenza kwabo esikoleni / emsebenzini.
Ngakolunye uhlangothi, abaphenduli abaneminyaka engama-55 nangaphezulu kubikwa ukuthi abathinteki kakhulu ngesimo sabo.
- Ama-52% wabaphenduli abaneminyaka engama-55 kuya kwengama-64 nama-51% abaneminyaka engama-65 nangaphezulu babike ukuthi badla okunempilo.
- Ama-26% wabaphenduli abaneminyaka engama-55 kuya kwengama-64 nama-23% abaneminyaka engama-65 nangaphezulu babike ukuthi isimo sabo asithinti impilo yabo yansuku zonke.
- Abangu-19% abaphendulile abaneminyaka engama-65 nangaphezulu babike ukuthi imikhuba yabo yokunakekelwa yisifo sikashukela ibavumele ukuba baphile impilo ephelele.
Cishe izingxenye ezimbili kwezintathu zabaphenduli kubikwa ukuthi zikhathazekile ngokuthi zisengozini enkulu yokuthola i-COVID-19 ngenxa yesifo sikashukela
Kwabaphenduli okubikwa ukuthi bakhathazekile, u-76% wabo ubephethwe yisifo sikashukela sohlobo 1. Lokhu kuyathakazelisa ngoba abantu abanesifo sikashukela sohlobo lwe-2 babonakala besengozini enkulu yokugula okunzima okuvela ku-coronavirus kunalabo abane-Type 1, ngokusho i-CDC .
- Ama-62% akhathazekile
- Ama-38% awakhathazeki
Uhlobo oluvame kakhulu lwemithi yesifo sikashukela phakathi kwalabo abathatha inhlolovo ngama-biguanides afana ne-metformin
| Amaphesenti wabathathi bezinhlolovo | Isigaba sezidakamizwa | Izibonelo zemithi ngaphakathi kwesigaba sezidakamizwa |
| 36% | Ama-Biguanides | I-Riomet , I-Fortamet , Amahlaya , I-Glucophage ( metformin ) |
| 19% | I-insulini | |
| 10% | I-Sulfonylureas | U-Amaryl , I-DiaBeta, i-Diabinese, I-Glucotrol ( glipizide ), EGlycron, UGlynase , Micronase, Tol-Tab, Tolinase |
| 9% | I-Incretin mimetics (i-GLP-1 agonists) | I-Adlyxin, Bydureon, Byetta ,, Trulicity , UVictoza , Ozempic |
| 7% | I-Gliptins (DPP-4 inhibitors) | Januwari , Galvus, Onglyza, Tradjenta, Nesina |
| 6% | Ama-Gliflozins (SGLT-2 inhibitors) | Steglatro, Injabulo , Invokana, I-Jardiance |
| 5% | Ama-Thiazolidinediones (TZDs) | I-Avandia , Izenzo |
| 4% | Imithi yokuhlanganiswa | I-Invokamet, UJanumet , Okufanayo |
| 3% | I-Alpha-glucosidase inhibitors (ama-AGIs) | I-Glyset , I-Precose |
| 3% | Ama-analogue ka-Amylin | I-Symlin |
| 3% | Meglitinides | I-Prandin, Inkanyezi |
Ngokwengeziwe, ama-5% wabaphenduli athatha eminye imithi engabhalisiwe ngenhla, kanti ama-31% awayiphuzi nhlobo imishanguzo yesifo sikashukela.
I-insulin esebenza isikhathi eside uhlobo oluvame kakhulu lwe-insulini phakathi kwabathathi bethu bohlolo
| Amaphesenti wabathathi bezinhlolovo | Uhlobo lwe-insulin | Izibonelo zama-insulins anegama lomkhiqizo |
| 14% | I-insulin esebenza isikhathi eside | Toujeo , I-Lantus , Levemir , UTresiba , I-Basaglar |
| 8% | I-insulin esebenza okwesikhashana | I-Humulin R, Humulin R U-500 , UNovolin R , Novolin ReliOn R |
| 8% | I-insulin esebenza ngokushesha | I-Novolog , I-Fiasp , Apidra, Humalog U-100, Humalog U-200, Admelog |
| 7% | I-insulin exubile | I-Humalog 50/50, i-Humalog 75/25, INovolog 70/30 , Humulin 70/30, Novolin 70/30 |
| 6% | I-insulin esebenza phakathi | Humulin N, UNovolin N , Novolin ReliOn N |
| 4% | I-powder yokuphefumula esebenza ngokushesha | Afrezz |
| 4% | Inhlanganisela ye-insulin | I-Xultophy , Soliqua |
Ngokwengeziwe, i-2% yabaphenduli bocwaningo bathatha enye i-insulin engabhalisiwe ngenhla.
OKUSHIWO: Imiphumela emibi ye-Metformin
Ukuchama njalo, ukukhathala, nezimpawu ze-GI kubikwa ukuthi yimiphumela emibi kakhulu yemithi yesifo sikashukela noma i-insulin
- Ama-24% abike ukuchama kaningi.
- Ukuchama njalo kuthinta abaphenduli besilisa abaningi (30%) kunabesifazane (18%).
- Ukuchama njalo kuthinta abaphenduli abaningi abaneminyaka engama-65 nangaphezulu (31%) kunamanye amaqembu eminyaka.
- Ama-24% abike ukukhathala.
- I-21% ibike imiphumela emibi ye-GI (ukucasula isisu, igesi, isifo sohudo, isicanucanu, ukuhlanza).
- Imiphumela emibi ye-GI ithinta abaphenduli besifazane abaningi (26%) kunabesilisa (17%).
- Imiphumela emibi ye-GI ithinta abaphenduli abaningi abaneminyaka engama-45 kuye kwengama-54 (30%) kunamanye amaqembu eminyaka.
- Abangu-11% babike ukulahleka kwesifiso.
- Ukuphela kwesifiso sokudla kuthinta abaphenduli besilisa abaningi (14%) kunabesifazane (8%).
- Ukuphelelwa isifiso sokudla kuthinta abaphenduli abaningi abaneminyaka engama-25 kuya kwengama-34 (19%) kanye nama-35 kuye kwangama-44 (15%) kunamanye amaqembu eminyaka yobudala.
- U-11% ubike ukwehla kwesisindo.
- Ukwehla kwesisindo kuthinta abaphenduli besilisa abaningi (14%) kunabesifazane (8%).
- Ukwehla kwesisindo kuthinta abaphenduli abaningi abaneminyaka engama-25 kuya kwengama-34 (19%) kanye nama-35 kuye kwangama-44 (15%) kunamanye amaqembu eminyaka yobudala.
- Ama-24% wabaphendulile ababike imikhuba yabo yokunakekelwa yisifo sikashukela ibavumele ukuthi baphile impilo ephelele futhi abangu-18% ababike ukuthi basebenzise kakhulu futhi babika ukwehla kwesisindo njengomphumela oseceleni.
- U-11% ubike ukuphefumula okuncane.
- Ukuphefumula okuncane kuthinta abaphenduli abaningi abaneminyaka engama-65 nangaphezulu (12%) kunamanye amaqembu eminyaka.
- U-10% ubike umchamo omnyama.
- U-8% ubike ukutheleleka ngemvubelo.
- Ukutheleleka ngemvubelo kuthinta abaphenduli besifazane abaningi (10%) kunabesilisa (6%).
- Ukutheleleka ngemvubelo kuthinta abaphenduli abaningi abaneminyaka engama-25 kuya kwengama-34 (15%) kunamanye amaqembu eminyaka.
- U-8% ubike umfutho wegazi ophansi.
- Umfutho wegazi ophansi uthinta abaphenduli abaningi abaneminyaka engama-25 kuya kwengama-34 (15%) kanye nama-35 kuye kwangama-44 (15%) kunamanye amaqembu eminyaka yobudala.
- U-8% ubike eminye imiphumela emibi (ukukhuluphala kwesisindo nobuhlungu obuhlangene nobethambo) noma kungabi bikho miphumela engemihle nakancane.
- U-6% ubike ukuvuvukala okukhulu.
- Ukuvuvukala okukhulu kuthinta abaphenduli abaningi abaneminyaka engama-55 kuya kwengama-64 (3%) kunamanye amaqembu eminyaka.
- 1% wabika i-lactic acidosis.
- Abangu-31% babike ukuthi abayiphuzi imishanguzo yesifo sikashukela noma i-insulin.
Imiphumela emibi ebikiwe yemithi yesifo sikashukela iqhathaniswa ne-insulin iyahluka
Kulabo abathatha imithi:
- Ama-34% abike imiphumela emibi ye-GI
- Ama-35% abike ukuchama kaningi
- U-32% ubike ukukhathala
- U-15% ubike ukuphefumula okuncane
- U-8% ubike ukutheleleka ngemvubelo
- U-5% ubike umfutho wegazi ophansi
Kulabo abathatha i-insulin:
- Ama-41% abike imiphumela emibi ye-GI
- Ama-27% abike ukulahleka kwesifiso
- U-18% ubike umchamo omnyama
Ama-54% wabaphenduli bakhokhela ephaketheni ukunakekelwa kwesifo sikashukela
Ngokusho kwe- I-American Diabetes Association (ADA) , U-67.3% wezokunakekelwa kwezempilo okuhlobene nesifo sikashukela (ukuhlolwa kweglucose egazini, imishanguzo, okuhlinzekwayo, ukuvakashelwa kwabahlinzeki bezempilo, njll.) Kumbozwe ngabakwaMedicare, Medicaid, noma abezempi; Ama-30.7% ahlanganiswa ngumshwalense wangasese; futhi kuphela u-2% wezindleko okhokhelwa ngabangaqinisekisiwe. Imiphumela yethu yocwaningo yatshela indaba efanayo.
- Ama-26% abike ukuthi umshuwalense ubhekelela konke ukunakekelwa kwabo yisifo sikashukela
- Ama-20% abike ukuthi iMedicare noma iMedicaid ihlanganisa konke ukunakekelwa kwabo yisifo sikashukela
- Abangu-16% babike ukuthi umshwalense uvikela kancane ukunakekelwa kwabo yisifo sikashukela
- Abangu-10% babike ukuthi iMedicare noma iMedicaid ihlanganisa ukunakekelwa kwesifo sikashukela
- Abangu-4% babike ukuthi bakhokha ephaketheni ngekhadi lesaphulelo esivela kadokotela (i-SingleCare, i-GoodRx, i-RxSaver, njll.) Ngokunakekelwa kwabo yisifo sikashukela
- U-3% ubike ukuthi bakhokha ephaketheni ngakho konke ukunakekelwa kwabo yisifo sikashukela
- Abangu-21% babike ukuthi abanakho ukunakekelwa kwesifo sikashukela
OKUSHIWO: Kubiza malini i-insulin?
Indlela yethu:
AbakwaSingleCare benze lolu cwaningo ngesifo sikashukela ku-inthanethi ngokusebenzisa i-AYTM ngo-Okthoba 3, 2020. Le datha yocwaningo ifaka abantu abadala base-U.S. Abaneminyaka yobudala eyi-18 + okubikwa ukuthi banesifo sikashukela. Ubulili buhlukaniswe ngo-50/50.
